Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers

Seminars in Liver Disease

Volumn 31, Issue 1, 2011, Pages 91-103

  Bioulac Sage, Paulette ^a   Cubel, Gaelle ^b   Balabaud, Charles ^c   Zucman Rossi, Jessica ^d  

^a HÔPITAL PELLEGRIN   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

^d Université Paris 13   (France)

Author keywords

catenin mutated hepatocellular adenoma; Focal nodular hyperplasia; hepatocellular adenoma; HNF1A mutated hepatocellular adenoma; inflammatory hepatocellular adenoma

Indexed keywords

BETA CATENIN; C REACTIVE PROTEIN; DANAZOL; FATTY ACID BINDING PROTEIN; GLUTAMATE AMMONIA LIGASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; SERUM AMYLOID A;

ADENOMATOUS POLYP; ARTICLE; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE 1; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMA, LIVER CELL; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951924787     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1272837     Document Type: Article

References (41)

1. Bioulac-Sage P, Laumonier H, Balabaud C. Benign hepatocellular tumors. In: Saxena R ed. Practical Hepatic Pathology: A Diagnostic Approach. Philadelphia Saunders 2011 In press
2. Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F Carneiro F Hruban R Theise N D. eds. Tumors of the Digestive Tract. Lyon, France World Health Organization, IARC 2010 198-204
3. Bluteau O, Jeannot E, Bioulac-Sage P et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002 32 2 312-315
4. Zucman-Rossi J, Jeannot E, Nhieu J T. et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006 43 3 515-524
5. Rebouissou S, Amessou M, Couchy G et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009 457 7226 200-204
6. Bioulac-Sage P, Rebouissou S, Thomas C et al. Hepatocellular adenoma subt (Pubitemid 47436120)
7. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008 48 1 163-170 (Pubitemid 350199576)
8. Bioulac-Sage P, Balabaud C, Bedossa P et al, Laennec and Elves groups. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007 46 3 521-527 (Pubitemid 46201719)
9. Paradis V, Laurent A, Flejou J F., Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997 26 4 891-895 (Pubitemid 27413654)
10. Paradis V, Bièche I, Dargère D et al. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003 124 3 651-659 (Pubitemid 36268484)
11. Rebouissou S, Couchy G, Libbrecht L et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008 49 1 61-71
12. Paradis V, Benzekri A, Dargère D et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004 126 5 1323-1329 (Pubitemid 38559002)
13. Bioulac-Sage P, Rebouissou S, Sa Cunha A et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005 128 5 1211-1218 (Pubitemid 40712173)
14. Bioulac-Sage P, Laumonier H, Rullier A et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 2009 29 3 459-465
15. Wanless I R., Albrecht S, Bilbao J et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 1989 2 5 456-462
16. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Focal nodular hyperplasia, hepatocellular adenomas: past, present, future. Gastroenterol Clin Biol 2010 34 6-7 355-358
17. Bioulac-Sage P, Laumonier H, Couchy G et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009 50 2 481-489
18. Flejou J F., Barge J, Menu Y et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985 89 5 1132-1138 (Pubitemid 16231581)
19. Lepreux S, Laurent C, Blanc J F. et al. The identification of small nodules in liver adenomatosis. J Hepatol 2003 39 1 77-85 (Pubitemid 36724111)
20. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008 48 3 808-818
21. Bacq Y, Jacquemin E, Balabaud C et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 2003 125 5 1470-1475 (Pubitemid 37409767)
22. Reznik Y, Dao T, Coutant R et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 2004 89 3 1476-1480 (Pubitemid 38368453)
23. Jeannot E, Mellottee L, Bioulac-Sage P et al, Groupe d'étude Génétique des Tumeurs Hépatiques (INSERM Network). Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 2010 59 7 1836-1844
24. Pelletier L, Rebouissou S, Paris A et al. Loss of HNF1a function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology 2010 51 2 557-566
25. Jeannot E, Poussin K, Chiche L et al. Association of CYP1B1 germline mutations with HNF1a mutated hepatocellular adenoma. Cancer Res 2007 67 6 2611-2616 (Pubitemid 46548947)
26. Ladeiro Y, Couchy G, Balabaud C et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008 47 6 1955-1963 (Pubitemid 351952843)
27. Rebouissou S, Imbeaud S, Balabaud C et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007 282 19 14437-14446 (Pubitemid 47100455)
28. Micchelli S T., Vivekanandan P, Boitnott J K., Pawlik T M., Choti M A., Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol 2008 21 4 491-497 (Pubitemid 351441041)
29. Paradis V, Champault A, Ronot M et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007 46 1 140-146 (Pubitemid 47171930)
30. Bioulac-Sage P, Laumonier H, Cubel G, Rossi J Z., Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int 2010 30 1 149-154
31. Sa Cunha A, Blanc J F., Lazaro E et al. Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. Gut 2007 56 2 307-309
32. Cassiman D, Libbrecht L, Verslype C et al. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol 2010 53 1 213-217
33. Velazquez I, Alter B P. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004 77 3 257-267 (Pubitemid 39430704)
34. Svrcek M, Jeannot E, Arrivé L et al. Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis. Eur J Endocrinol 2007 156 6 617-621 (Pubitemid 46952530)
35. Jeannot E, Wendum D, Paye F et al. Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol 2006 45 6 883-886 (Pubitemid 44754788)
36. Toso C, Rubbia-Brandt L, Negro F, Morel P, Mentha G. Hepatocellular adenoma and polycystic ovary syndrome. Liver Int 2003 23 1 35-37 (Pubitemid 37265772)
37. Watkins J, Balabaud C, Bioulac-Sage P, Sharma D, Dhillon A. Hepatocellular adenoma in advanced-stage fatty liver disease. Eur J Gastroenterol Hepatol 2009 21 8 932-936
38. Brunt E M., Wolverson M K., Di Bisceglie A M. Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report. Semin Liver Dis 2005 25 2 230-236 (Pubitemid 40781075)
39. Terkivatan T, Ijzermans J N. Hepatocellular adenoma: Should phenotypic classification direct management? Nat Rev Gastroenterol Hepatol 2009 6 12 697-698
40. Dokmak S, Paradis V, Vilgrain V et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009 137 5 1698-1705
41. Vetel?inen R, Erdogan D, de Graaf W et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008 28 4 499-508 (Pubitemid 351411136)